Related references
Note: Only part of the references are listed.Platinum Intercalators of DNA as Anticancer Agents
Benjamin J. Pages et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2017)
Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: Syntheses, characterization, and in vitro cytotoxicity studies
Carlson Alexander et al.
INORGANIC CHEMISTRY COMMUNICATIONS (2017)
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
Timothy C. Johnstone et al.
CHEMICAL REVIEWS (2016)
Multifaceted Studies of the DNA Interactions and In Vitro Cytotoxicity of Anticancer Polyaromatic Platinum(II) Complexes
Benjamin J. Pages et al.
CHEMISTRY-A EUROPEAN JOURNAL (2016)
Oxidative halogenation of cisplatin and carboplatin: synthesis, spectroscopy, and crystal and molecular structures of Pt(IV) prodrugs
Timothy C. Johnstone et al.
DALTON TRANSACTIONS (2015)
Photoactivatable platinum(II) compounds: in search of novel anticancer drugs
Jose P. Ceron-Carrasco et al.
THEORETICAL CHEMISTRY ACCOUNTS (2015)
Surface confined heteroleptic copper(II)-polypyridyl complexes for photonuclease activity
Vikram Singh et al.
CHEMICAL COMMUNICATIONS (2014)
Synthetic Methods for the Preparation of Platinum Anticancer Complexes
Justin J. Wilson et al.
CHEMICAL REVIEWS (2014)
Labelling Herceptin with a novel oxaliplatin derivative: a computational approach towards the selective drug delivery
Jose P. Ceron-Carrasco et al.
JOURNAL OF MOLECULAR MODELING (2014)
The calculations of excited-state properties with Time-Dependent Density Functional Theory
Carlo Adamo et al.
CHEMICAL SOCIETY REVIEWS (2013)
Nedaplatin: a cisplatin derivative in cancer chemotherapy
Muneaki Shimada et al.
Cancer Management and Research (2013)
Cisplatin cytotoxicity: a theoretical study of induced mutations
Jose P. Ceron-Carrasco et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
The status of platinum anticancer drugs in the clinic and in clinical trials
Nial J. Wheate et al.
DALTON TRANSACTIONS (2010)
Mechanistic insight into the cellular uptake and processing of cisplatin 30 years after its approval by FDA
Fabio Arnesano et al.
COORDINATION CHEMISTRY REVIEWS (2009)
Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting
Katherine S. Lovejoy et al.
DALTON TRANSACTIONS (2009)
The mechanism of action of platinum anticancer agents-what do we really know about it?
Dan Gibson
DALTON TRANSACTIONS (2009)
Inhibition of transcription by platinum antitumor compounds
Ryan C. Todd et al.
METALLOMICS (2009)
Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature
Sumitra Mukhopadhyay et al.
BIOCONJUGATE CHEMISTRY (2008)
A Non-Cross-Linking Platinum-Acridine Agent with Potent Activity in Non-Small-Cell Lung Cancer
Zhidong Ma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Basis for design and development of Platinum(IV) anticancer complexes
Matthew D. Hall et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Direct cellular responses to platinum-induced DNA damage
Yongwon Jung et al.
CHEMICAL REVIEWS (2007)
Bifunctional binding of cisplatin to DNA: Why does cisplatin form 1,2-intrastrand cross-links with AG but not with GA?
Yogita Mantri et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin
Alison K. Holzer et al.
MOLECULAR PHARMACOLOGY (2006)
Satraplatin: an orally available platinum analog for the treatment of cancer
Hak Choy
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
The discovery and development of cisplatin
RA Alderden et al.
JOURNAL OF CHEMICAL EDUCATION (2006)
Hydrolysis of the anticancer drug cisplatin: Pitfalls in the interpretation of quantum chemical calculations
JKC Lau et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2006)
Optimization, application, and interpretation of lactate dehydrogenase measurements in microwell determination of cell number and toxicity
HT Wolterbeek et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2005)
Hydration process as an activation of trans- and cisplatin complexes in anticancer treatment.: DFT and ab initio computational study of thermodynamic and kinetic parameters
JV Burda et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Hydrogen bonding and covalent effects in binding of cisplatin to purine bases: Ab initio and atoms in molecules studies
A Robertazzi et al.
INORGANIC CHEMISTRY (2005)
Activation of anti-cancer drug cisplatin - is the activated complex fully aquated?
J Raber et al.
MOLECULAR PHYSICS (2004)
Theoretical study of cisplatin binding to purine bases: Why does cisplatin prefer guanine over adenine?
MH Baik et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
How strong can the bend be on a DNA helix from cisplatin? DFT and MP2 quantum chemical calculations of cisplatin-bridged DNA purine bases
JV Burda et al.
INORGANIC CHEMISTRY (2003)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
Biochemical modulation of cisplatin mechanisms of action:: Enhancement of antitumor activity and circumvention of drug resistance
MA Fuertes et al.
CHEMICAL REVIEWS (2003)
Retention of activity by the new generation platinum agent AMD0473 in four human tumour cell lines possessing acquired resistance to oxaliplatin
SY Sharp et al.
EUROPEAN JOURNAL OF CANCER (2002)
Platinum(IV) antitumour compounds: their bioinorganic chemistry
MD Hall et al.
COORDINATION CHEMISTRY REVIEWS (2002)
2.4 Å crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex
B Spingler et al.
INORGANIC CHEMISTRY (2001)
Hydrolysis theory for cisplatin and its analogues based on density functional studies
Y Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Recognition of cisplatin adducts by cellular proteins
M Kartalou et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
Correlation consistent valence basis sets for use with the Stuttgart-Dresden-Bonn relativistic effective core potentials: The atoms Ga-Kr and In-Xe
JML Martin et al.
JOURNAL OF CHEMICAL PHYSICS (2001)
Estimating the number of viable animal cells in multi-well cultures based on their lactate dehydrogenase activities
G Haslam et al.
CYTOTECHNOLOGY (2000)
Share Paper
